Skip to content

A randomized, controlled clinical trial: The effects of mindfulness-based cognitive therapy on chronic insomnia among Chinese patients in the community

A randomized, controlled clinical trial: The effects of mindfulness-based cognitive therapy on chronic insomnia among Chinese patients in the community

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-12002535
Enrollment
Unknown
Registered
2012-09-28
Start date
2012-10-13
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Insomnia

Interventions

MBCT:MBCT course

Sponsors

JC School of Public Health and Primary Care, the Chinese University of Hong Kong
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. being 18 years of age or older; 2. having, at baseline assessment, chronic insomnia based on established criteria (DSM IV and ICD-10 combined) that include: (1) difficulties initiating and/or maintaining sleep, defined as a sleep onset latency and /or wake after sleep onset greater than 30 minutes, with a corresponding sleep time of less than 6.5 hours at least 3 nights per week as measured by daily sleep diaries; (2) duration of longer than 6 months and c) significant impairment of daytime functioning (rating of >=2 on item 5 of the Insomnia Severity Index [ISI]; 3. can understand Cantonese; 4. are willing to attend the mindfulness-based cognitive therapy program; 5. are willing to discontinue their sleep medications for a period of 2 weeks (washout period) prior to enrolling in the study or agree to keep constant the dosage and frequency of sleep medication during the study period among those who regularly use sleep medications.

Exclusion criteria

Exclusion criteria: 1. illiterate subjects as they will not be able to complete the meditation diary or PEC work sheet and questionnaires; 2. psychiatric and medical co-morbidities that are potentially life threatening (i.e. psychosis, suicidal ideation, terminal medical illness) or conditions expected to severely limit patient participation or adherence (e.g. psychosis, current substance or alcohol abuse, dementia, pregnancy); 3. presence of a progressive medical illness such as dementia that is directly related to the onset and course of insomnia; 4. screened positive for major depression, eating disorder, substance abuse or anxiety disorder using the Primary Health Questionnaire (PHQ); 5. presence of psychotic symptoms or disorder; 6. night shift work; 7. those already using cognitively behavioural therapy or are planning to start cognitive behavioural therapy.

Design outcomes

Primary

MeasureTime frame
Insomnia severity index and sleep diary;

Countries

China

Contacts

Public ContactSamuel Yeung Shan, WONG
yeungshanwong@cuhk.edu.hk+852 22528774

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026